HIF-1α expression in response to lipopolysaccaride mediates induction of hepatic inflammatory cytokine TNFα

被引:35
作者
Kim, Hye Young
Kim, Young Hee
Nam, Bo-Hye
Kong, Hee Jeong
Kim, Hyung Hoi
Kim, Yoon Jin
An, Won Gun
Cheong, JaeHun [1 ]
机构
[1] Pusan Natl Univ, Dept Biol Mol, Pusan 609735, South Korea
[2] NFRDI, Biotechnol Res Ctr, Pusan 619902, South Korea
[3] Pusan Natl Univ, Coll Med, Dept Expt Med, Pusan 602737, South Korea
[4] Pusan Natl Univ, Coll Med, Dept Family Med, Pusan 602737, South Korea
[5] Pusan Natl Univ, Dept Nanosci, Pusan 609735, South Korea
关键词
LPS; HIF-1; alpha; JNK/c-Jun; Egr-1; TNF alpha; inflammation;
D O I
10.1016/j.yexcr.2007.03.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HIF-1 alpha is a transcription factor that acts as a master regulator of gene expression induced by hypoxia. Recent studies have demonstrated that the potent inflammatory factor, lipopolysaccharide (LPS), can also activate HIF-1 alpha in myeloid cells. However, the molecular mechanisms at the transcriptional level of HIF-1 alpha induction by LPS remained undefined. Here, we investigated the regulatory mechanism of HIF-1 alpha expression by LPS in hepatocytes and identified that LPS-induced HIF-1 alpha mediate gene transcription of a typical inflammatory mediator, tumor-necrosis factor alpha (TNF alpha). Increased HIF-1 alpha gene expression by LPS was defined in a series of hepatic cell lines by RT-PCR, Western blotting and promoter transactivation assay. The JNK signaling and c-Jun activation were required to induce the HIF-1 alpha gene transcription by LPS. The finding that a cascade transcriptional activation of distinct set of transcription factors, c-Jun and HIF-1 alpha, in response to LPS stimulation associates with induction of TNF alpha gene transcription lends new insights into the functional mechanisms by which complex patterns of gene regulation on LPS-derived HIF activation are achieved. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1866 / 1876
页数:11
相关论文
共 44 条
[21]  
Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1
[22]  
Lejeune Ferdy J, 2006, Cancer Immun, V6, P6
[23]   Tumor necrosis factor: How to make a killer molecule tumor-specific? [J].
Lucas, R ;
Kresse, M ;
Latta, M ;
Wendel, A .
CURRENT CANCER DRUG TARGETS, 2005, 5 (06) :381-392
[24]   Expression of hypoxia inducible factor-1α during liver regeneration induced by partial hepatectomy in rats [J].
Maeno, H ;
Ono, T ;
Dhar, DK ;
Sato, T ;
Yamanoi, A ;
Nagasue, N .
LIVER INTERNATIONAL, 2005, 25 (05) :1002-1009
[25]   Hypoxia-inducible factor as a physiological regulator [J].
Maxwell, PH .
EXPERIMENTAL PHYSIOLOGY, 2005, 90 (06) :791-797
[26]   The HIF pathway in cancer [J].
Maxwell, PH .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2005, 16 (4-5) :523-530
[27]   Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer [J].
Mizukami, Y ;
Li, JN ;
Zhang, XB ;
Zimmer, MA ;
Iliopoulos, O ;
Chung, DC .
CANCER RESEARCH, 2004, 64 (05) :1765-1772
[28]   Protein kinase Cα requirement in the activation of p38 mitogen-activated protein kinase, which is linked to the induction of tumor necrosis factor α in lipopolysaccharide-stimulated microglia [J].
Nakajima, K ;
Tohyama, Y ;
Kohsaka, S ;
Kurihara, T .
NEUROCHEMISTRY INTERNATIONAL, 2004, 44 (04) :205-214
[29]   Ethanol-induced liver injury: Potential role for Egr-1 [J].
Pritchard, MT ;
Nagy, LE .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (11) :146S-150S
[30]   Current understanding of HIF in renal disease [J].
Rosenberger, C ;
Rosen, S ;
Heyman, SN .
KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (5-6) :325-340